- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 13.08. | Bluejay Diagnostics reports Q2 results | 1 | Seeking Alpha | ||
| 13.08. | Bluejay Diagnostics, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 13.08. | Bluejay Diagnostics completes enrollment in sepsis test study | 1 | Investing.com | ||
| 13.08. | Bluejay Diagnostics, Inc.: Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony IL-6 Toward Regulatory Submission and Commercialization | 393 | GlobeNewswire (Europe) | SYMON-II pivotal clinical study completes targeted enrollment of 750 patientsCompany advances toward planned 510(k) submission and commercialization with US manufacturing contract signed to mitigate... ► Artikel lesen | |
| BLUEJAY DIAGNOSTICS Aktie jetzt für 0€ handeln | |||||
| 12.08. | Bluejay Diagnostics, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
| 22.07. | Bluejay Diagnostics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 21.07. | Bluejay Diagnostics, Inc.: Bluejay Diagnostics Announces Successful Completion of Enrollment in the SYMON-II Multicenter Clinical Validation Study | 266 | GlobeNewswire (Europe) | ACTON, Mass., July 21, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX), a medical diagnostics company developing rapid, near-patient diagnostic technologies for critical care, today... ► Artikel lesen | |
| 09.06. | Bluejay Diagnostics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 06.06. | Bluejay Diagnostics closes $8.5 million private placement | 1 | Investing.com | ||
| 06.06. | Bluejay Diagnostics, Inc.: Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules | 1 | GlobeNewswire (USA) | ||
| 03.06. | What's Going On With Bluejay Diagnostics Shares On Wednesday? | 3 | Benzinga.com | ||
| 02.06. | Bluejay Diagnostics raises $8.5M in private placement | 2 | Investing.com | ||
| 02.06. | Bluejay Diagnostics, Inc.: Bluejay Diagnostics Announces up to $23.6 Million Private Placement Priced At-the-Market Under Nasdaq Rules | 4 | GlobeNewswire (USA) | ||
| 02.06. | Why Is Bluejay Diagnostics Stock Soaring Tuesday? | 7 | Benzinga.com | ||
| 02.06. | Morning Market Movers: Bluejay Diagnostics, Decent Holding, Abits Group, Sunshine Biopharma See Big Swings | 739 | AFX News |
WASHINGTON (dpa-AFX) - At 7:35 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| 02.06. | Bluejay Diagnostics partners with Argonaut for US manufacturing | 4 | Investing.com | ||
| 02.06. | Bluejay Diagnostics, Inc.: Bluejay Diagnostics and Argonaut Manufacturing Services Announce Strategic Partnership | 246 | GlobeNewswire (Europe) | ACTON, Mass. and CARLSBAD, Calif., June 02, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. ("Bluejay" or the "Company") (NASDAQ: BJDX), a medical diagnostics company focused on near-patient testing... ► Artikel lesen | |
| 02.06. | Bluejay Diagnostics, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 07.05. | Bluejay Diagnostics, Inc.: Bluejay Diagnostics Provides First Quarter 2026 Corporate Update | 218 | GlobeNewswire (Europe) | ACTON, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. ("Bluejay" or the "Company"), a medical diagnostics company focused on improving patient outcomes in critical care settings... ► Artikel lesen | |
| 07.05. | Bluejay Diagnostics, Inc. - 10-Q, Quarterly Report | - | SEC Filings |
1 2 Weiter >>
29 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CARL ZEISS MEDITEC | 32,880 | +0,55 % | Vom Patent zum Umsatz: Wie Health-Tech-Innovationen den Milliardenmarkt Augengesundheit erreichen - und warum für Rise Nano Optics jetzt die entscheidende Phase beginnt | ||
| HIMS & HERS HEALTH | 24,700 | +0,57 % | Reasons to Retain Hims & Hers Stock in Your Portfolio for Now | ||
| ATOSSA THERAPEUTICS | 2,100 | -0,94 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Aug. 7, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel... ► Artikel lesen | |
| GE HEALTHCARE TECHNOLOGIES | 61,58 | +1,33 % | GE HealthCare's Photonova Spectra gains CE Mark, expanding international access | Following U.S. FDA 510(k) clearance and Japanese regulatory approval, Photonova Spectra has also achieved CE Mark, supporting expanded research and clinical adoption across Europe and other global... ► Artikel lesen | |
| CLOVER HEALTH INVESTMENTS | 3,670 | -1,08 % | Clover Health Investments, Corp.: Clover Health Announces Departure of Chief Financial Officer and Appointment of Interim Chief Financial Officer; Reiterates Most Recently Issued Financial Guidance for Full Fiscal Year 2026 | WILMINGTON, Del., April 01, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) ("Clover" or the "Company"), a physician enablement company committed to bringing access to great... ► Artikel lesen | |
| BUTTERFLY NETWORK | 6,653 | -5,79 % | Butterfly Network licenses ultrasound tech to Merge Labs for BCI | ||
| BEYOND AIR | 3,620 | 0,00 % | Beyond Air Receives FDA Breakthrough Device Designation for LungFit GO to Treat Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD) | GARDEN CITY, N.Y., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) ("Beyond Air" or the "Company"), a commercial-stage medical device and biopharmaceutical company focused on harnessing... ► Artikel lesen | |
| AETHLON MEDICAL | 1,830 | 0,00 % | AETHLON MEDICAL INC - 8-K, Current Report | ||
| AVANOS MEDICAL | 21,600 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 27.07.2026 | The following instruments on Boerse Frankfurt do have their last trading day on 27.07.2026.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 27.07.2026.ISIN NameCA05335P1099 AUXLY... ► Artikel lesen | |
| ANGIODYNAMICS | 13,900 | +1,46 % | Biotech Stocks At 52-Week Highs - Cumberland Pharmaceuticals, Maravai LifeSciences, AngioDynamics, Acadia Healthcare, Teladoc Health | BENTONVILLE (dpa-AFX) - The following biotech stocks reached a 52-week high on July 15, 2026, driven by catalysts such as recent business developments or positive quarterly reports.Cumberland... ► Artikel lesen | |
| APYX MEDICAL | 2,660 | +0,76 % | Apyx Medical Corporation Reports Second Quarter 2026 Financial Results | Reported total revenue of $13.9 million in the second quarter of 2026 primarily driven by 28% growth in the Surgical Aesthetics segmentSuccessful limited launch of the power liposuction handpiece... ► Artikel lesen | |
| ANTERIS TECHNOLOGIES GLOBAL | 8,590 | 0,00 % | Anteris Technologies Global Corp.: Anteris Technologies Announces Results for the Second Quarter of 2026 | MINNEAPOLIS and BRISBANE, Australia, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. ("Anteris" or the "Company") (NASDAQ: AVR, ASX: AVR) a global healthcare company committed... ► Artikel lesen | |
| ADAPTHEALTH | 6,050 | +0,17 % | Morning Market Movers: Ameresco, Inno Holdings, AdaptHealth, Ibotta See Big Swings | OTTAWA (dpa-AFX) - At 7:50 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| AVITA MEDICAL | 9,300 | +8,14 % | AVITA Medical Reports First Quarter 2026 Financial Results | VALENCIA, Calif., May 14, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions ("AVITA Medical... ► Artikel lesen | |
| AUTONOMIX MEDICAL | 4,500 | 0,00 % | Morning Market Movers: Gran Tierra Energy, Autonomix Medical, Julong Holding, Shopify See Big Swings | OTTAWA (dpa-AFX) - At 7:55 a.m. ET on Wednesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen |
Das Unternehmen BLUEJAY DIAGNOSTICS INC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,843 Euro und damit -0,77 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BLUEJAY DIAGNOSTICS INC finden Sie auf Wallstreet Online.